Medical equipment industry

United States. Securities and Exchange Commission

SEC Filing Reveals Details of Arrhythmia Research Technology Inc.'s Corporate Changes

U.S. Securities and Exchange Commission (SEC) filings provide critical information for investors and security holders, offering a glimpse into the latest developments within publicly-traded companies. On July 23, 2015, Arrhythmia Research Technology Inc. submitted a Form 8-K filing, detailing three documents and significant corporate changes. This filing marks a

United States. Securities and Exchange Commission

Teleflex Incorporated Announces Long-Term Financial Goals and Reaffirms 2015 Guidance

Teleflex Incorporated, a Delaware-based company, filed a Form 8-K with the Securities and Exchange Commission on May 21, 2015, announcing its longer-term financial goals and objectives, which it planned to discuss later that day during its investor and analyst conference. The company reaffirmed its previously provided 2015 constant currency revenue